EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

A distinct subset of urothelial cells with enhanced EMT features promotes chemotherapy resistance and cancer recurrence by increasing COL4A1-ITGB1 mediated angiogenesis

Jinan Guo, Xiaoshi Ma, Dongcheng Liu, Fei Wang, Jinquan Xia, Bin Zhang, Pan Zhao, Fuhua Zhong, Lipeng Chen, Qiaoyun Long, Lu Jiang, Siyu Zhang und 8 weitere

Drug Resistance Updates · 2024-09 · 76 · 101116

DOI: 10.1016/j.drup.2024.101116 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Resistance Updates, 2024-09. Verfasst von Jinan Guo und 19 weiteren Autor:innen. Beteiligte Einrichtung: The First Affiliated Hospital of Southern University of Science and Technology, Shenzhen, Guangdong, PR China. Hauptthemen laut MEDLINE: Collagen Type IV, Drug Resistance, Neoplasm, Epithelial-Mesenchymal Transition, Integrin beta1. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Basic and Applied Basic Research Foundation of Guangdong Province, National Natural Science Foundation of China, Guangdong Provincial Natural Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Drug resistance and tumor recurrence remain clinical challenges in the treatment of urothelial carcinoma (UC). However, the underlying mechanism is not fully understood. Here, we performed single-cell RNA sequencing and identified a subset of urothelial cells with epithelial-mesenchymal transition (EMT) features (EMT-UC), which is significantly correlated with chemotherapy resistance and cancer recurrence. To validate the clinical significance of EMT-UC, we constructed EMT-UC like cells by introducing overexpression of two markers, Zinc Finger E-Box Binding Homeobox 1 (ZEB1) and Desmin (DES), and examined their histological distribution characteristics and malignant phenotypes. EMT-UC like cells were mainly enriched in UC tissues from patients with adverse prognosis and exhibited significantly elevated EMT, migration and gemcitabine tolerance in vitro. However, EMT-UC was not specifically identified from tumorous tissues, certain proportion of them were also identified in adjacent normal tissues. Tumorous EMT-UC highly expressed genes involved in malignant behaviors and exhibited adverse prognosis. Additionally, tumorous EMT-UC was associated with remodeled tumor microenvironment (TME), which exhibited high angiogenic and immunosuppressive potentials compared with the normal counterparts. Furthermore, a specific interaction of COL4A1 and ITGB1 was identified to be highly enriched in tumorous EMT-UC, and in the endothelial component. Targeting the interaction of COL4A1 and ITGB1 with specific antibodies significantly suppressed tumorous angiogenesis and alleviated gemcitabine resistance of UC. Overall, our findings demonstrated that the driven force of chemotherapy resistance and recurrence of UC was EMT-UC mediated COL4A1-ITGB1 interaction, providing a potential target for future UC treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Collagen Type IVDrug Resistance, NeoplasmEpithelial-Mesenchymal TransitionIntegrin beta1Neoplasm Recurrence, LocalNeovascularization, PathologicUrinary Bladder NeoplasmsHumansCell Line, TumorCell MovementDeoxycytidineGemcitabineGene Expression Regulation, NeoplasticPrognosisTumor MicroenvironmentUrotheliumZinc Finger E-box-Binding Homeobox 1

Stichwörter der Autor:innen

COL4A1-ITGB1 InteractionChemotherapy resistance and recurrenceSingle-cell RNA sequencingTumor microenvironmentUrothelial carcinoma

Substanzen

COL4A1 protein, humanCollagen Type IVDeoxycytidineGemcitabineIntegrin beta1Itgb1 protein, humanZinc Finger E-box-Binding Homeobox 1

Autor:innen und Institutionen

  • The First Affiliated Hospital of Southern University of Science and Technology, Shenzhen, Guangdong, PR China.
  • The Second Affiliated Hospital of Southern University of Science and Technology, Shenzhen, Guangdong, PR China.
  • The First Affiliated Hospital of Southern University of Science and Technology, Shenzhen, Guangdong, PR China; Shenzhen Aier Eye Hospital, Shenzhen, Guangdong, PR China.
  • Hainan Affiliated Hospital of Hainan Medical University, Hainan General Hospital, Haikou, Hainan, PR China.
  • The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, PR China.
  • The Third Affiliated Hospital of Shenzhen University, Shenzhen, Guangdong, PR China.

Förderung

  • Basic and Applied Basic Research Foundation of Guangdong Province
  • National Natural Science Foundation of China
  • Guangdong Provincial Natural Science Foundation
  • Guangdong Medical Research Foundation
  • Science and Technology Foundation of Shenzhen City

Zitieren

APA

Guo, J., Ma, X., Liu, D., Wang, F., Xia, J., Zhang, B., Zhao, P., Zhong, F., Chen, L., Long, Q., Jiang, L., Zhang, S., Liao, N., Wang, J., Wu, W., Sun, J., Huang, M., Cheng, Z., Huang, G., & Zou, C. (2024). A distinct subset of urothelial cells with enhanced EMT features promotes chemotherapy resistance and cancer recurrence by increasing COL4A1-ITGB1 mediated angiogenesis. Drug Resistance Updates, 76, 101116. https://doi.org/10.1016/j.drup.2024.101116

Vancouver

Guo J, Ma X, Liu D, Wang F, Xia J, Zhang B, et al. A distinct subset of urothelial cells with enhanced EMT features promotes chemotherapy resistance and cancer recurrence by increasing COL4A1-ITGB1 mediated angiogenesis. Drug Resistance Updates. 2024;76:101116. doi:10.1016/j.drup.2024.101116

BibTeX
@article{Guo2024,
  author = {Guo, Jinan and Ma, Xiaoshi and Liu, Dongcheng and Wang, Fei and Xia, Jinquan and Zhang, Bin and Zhao, Pan and Zhong, Fuhua and Chen, Lipeng and Long, Qiaoyun and Jiang, Lu and Zhang, Siyu and Liao, Naikai and Wang, Jigang and Wu, Weiqing and Sun, Jichao and Huang, Mou and Cheng, Zhiqiang and Huang, Guixiao and Zou, Chang},
  title = {A distinct subset of urothelial cells with enhanced EMT features promotes chemotherapy resistance and cancer recurrence by increasing COL4A1-ITGB1 mediated angiogenesis},
  journal = {Drug Resistance Updates},
  year = {2024},
  volume = {76},
  pages = {101116},
  doi = {10.1016/j.drup.2024.101116}
}
Kostenlos starten →